Huberman Lab
Dr. Matthew Hill: How Cannabis Impacts Health & the Potential Risks
Andrew Huberman
Right now, things are really on the teeter-totter with MDMA, where we await the decision from the FDA, but the early recommendation to the FDA was to not approve MDMA as a treatment for PTSD. So today, in mid to late June 2024, we'll see what happens.
0
💬
0
Comments
Log in to comment.
There are no comments yet.